Sanofi in $1 Bln Deal to Buy U.S.-Based Amunix Pharma

PARIS — Drugmaker Sanofi SA will buy Amunix Pharmaceuticals Inc for an upfront payment of about $1 billion, marking the latest acquisition by the French drugmaker in the U.S. biotech sphere as Sanofi aims to offset COVID-19 vaccine setbacks. Read More